Joseph Talamo's most recent trade in Intensity Therapeutics Inc was a trade of 34,000 Stock Option (right to buy Common Stock) done . Disclosure was reported to the exchange on July 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 34,000 | 34,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.48 per share. | 30 Jun 2026 | 1,093 | 2,239 | - | 3.5 | 3,809 | Common Stock, $0.0001 Par Value |
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.26 per share. | 31 Dec 2025 | 14,482 | 28,661 | - | 0.3 | 3,794 | Common Stock, $0.0001 Par Value |
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.26 per share. | 30 Jun 2025 | 14,179 | 14,179 | - | 0.3 | 3,701 | Common Stock, $0.0001 Par Value |
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 300,000 | 300,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 427,379 | 427,379 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Joseph Talamo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy Common Stock) |